GALT·363225202·US·equity·Healthcare - Biotechnology
GALT (GALECTIN THERAPEUTICS INC) is held by 59 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($3.4M), OSAIC HOLDINGS, INC. ($3.1M), BlackRock, Inc. ($2.2M). Net institutional sentiment: Mixed.
See how GALT's score breaks down across 4 SEC sources
Showing 1-20 of 65
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer